1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Renal Anemia-Pipeline Insights, 2014

Renal Anemia-Pipeline Insights, 2014

  • August 2014
  • -
  • Delve Insight

SUMMARY
DelveInsight’s,“ Renal Anemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Renal Anemia. This report provides information on the therapeutic development based on the Renal Anemia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Renal Anemia
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Renal Anemia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Renal Anemia and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Renal Anemia
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Renal Anemia pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Renal Anemia-Pipeline Insights, 2014
Table of Contents
- Renal Anemia Overview
- Renal Anemia Pipeline Therapeutics
- Renal Anemia Therapeutics under Development by Companies
- Renal Anemia Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Renal Anemia Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Renal Anemia Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Renal Anemia Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Renal Anemia - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Renal Anemia - Discontinued Products
- Renal Anemia - Dormant Products
- Companies Involved in Therapeutics Development for Renal Anemia
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Renal Anemia, 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Renal Anemia Assessment by Monotherapy Products
- Renal Anemia Assessment by Combination Products
- Renal Anemia Assessment by Route of Administration
- Renal Anemia Assessment by Stage and Route of Administration
- Renal Anemia Assessment by Molecule Type
- Renal Anemia Assessment by Stage and Molecule Type
- Renal Anemia Therapeutics - Discontinued Products
- Renal Anemia Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Renal Anemia, 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Renal Anemia Assessment by Monotherapy Products
- Renal Anemia Assessment by Combination Products
- Renal Anemia Assessment by Route of Administration
- Renal Anemia Assessment by Stage and Route of Administration
- Renal Anemia Assessment by Molecule Type
- Renal Anemia Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hemophilia Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Hemophilia Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Hemophilia Treatment Drugs Market: Overview Hemophilia is a rare blood disorder. Hemophilia is a combination of two Greek words that is haima (blood) and philia (affection). Hemophilia is a hereditary ...

Apheresis Market by Product, Procedure, Application, Technology - Global Forecast to 2021

Apheresis Market by Product, Procedure, Application, Technology - Global Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence ...

Epiomic Epidemiology Series: Polycythemia Vera Forecast in 27 Major Markets 2016-2026

Epiomic Epidemiology Series: Polycythemia Vera Forecast in 27 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • December 2016
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Polycythemia Vera in 27 Major Markets Polycythemia Vera (PV), also known as erythraemia, erythrocytosis, erythrocytosis megalosplenica, ...

Global Genetic Testing Market

December 2016 $ 4250

Download Unlimited Documents from Trusted Public Sources

Blood Disease Statistics in the US - Forecast

  • March 2017
    10 pages
  • Blood Disease  

    Compression The...  

    Cardiovascular ...  

  • United States  

View report >

Blood Disease Statistics in the US

  • March 2017
    5 pages
  • Blood Disease  

    Pumpkin  

  • United States  

View report >

Blood Disease Statistics in the Netherlands

  • March 2017
    10 pages
  • Blood Disease  

    Intensive Care  

  • Netherlands  

View report >

Related Market Segments :

Blood Disease

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.